title: Getting cytisine licensed for use world-wide: a call to action.
authors.affiliation: National Institute for Health Innovation and Centre for Addiction Research, School of Population Health, University of Auckland, Auckland, New Zealand. n.walker@auckland.ac.nz.
authors.forename: Natalie
authors.initials: N
authors.lastname: Walker
authors.affiliation: National Institute for Health Innovation, School of Population Health, University of Auckland, Auckland, New Zealand.
authors.forename: Chris
authors.initials: C
authors.lastname: Bullen
authors.affiliation: School of Pharmacy, University of Auckland, Auckland, New Zealand.
authors.forename: Joanne
authors.initials: J
authors.lastname: Barnes
authors.affiliation: Queen Mary University of London, London, UK.
authors.forename: Hayden
authors.initials: H
authors.lastname: McRobbie
authors.affiliation: Department of Pharmacology, Centre for Innovative Research for Medical and Natural Sciences, University of Rzeszów, Rzeszów, Poland.
authors.forename: Piotr
authors.initials: P
authors.lastname: Tutka
authors.affiliation: UK Centre for Tobacco Control Studies, University of Nottingham, Nottingham, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: Raw
authors.affiliation: Faculty of Medicine, University of Geneva, Geneva, Switzerland.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Etter
authors.affiliation: Department of Health Sciences, University of York, York, UK.
authors.forename: Kamran
authors.initials: K
authors.lastname: Siddiqi
authors.affiliation: National Drug and Alcohol, Research Centre, University of New South Wales, Sydney, Australia.
authors.forename: Ryan J
authors.initials: RJ
authors.lastname: Courtney
authors.affiliation: Department of Neuroscience, Medical School, Fundação do ABC, Santo André, Brazil.
authors.forename: João Mauricio
authors.initials: JM
authors.lastname: Castaldelli-Maia
authors.affiliation: Departments of Family and Community Medicine, Psychiatry and Public Health Sciences, University of Toronto, Toronto, Canada.
authors.forename: Peter
authors.identifier: 0000-0001-5401-2996
authors.initials: P
authors.lastname: Selby
authors.affiliation: School of Pharmacy and Centre for Addiction Research, University of Auckland, Auckland, New Zealand.
authors.forename: Janie
authors.initials: J
authors.lastname: Sheridan
authors.affiliation: Harvard Medical School, Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, USA.
authors.forename: Nancy A
authors.initials: NA
authors.lastname: Rigotti
mesh_terms: D000470:Alkaloids; D001392:Azocines; D007880:Legislation, Drug; D009538:Nicotine; D011807:Quinolizines; D016540:Smoking Cessation; D000093843:Quinolizidine Alkaloids
chemical_list: D000470:Alkaloids; D001392:Azocines; D009538:Nicotine; D011807:Quinolizines; C004712:cytisine; D000093843:Quinolizidine Alkaloids
keywords: Affordable; cost-effective; cytisine; regulatory approval; smoking cessation; treatment